Reference
Lin, H. V., Efanov, A. M., Fang, X., Beavers, L. S., Wang, X., Wang, J., Valcarcel, I. C. G., & Ma, T. (2016). GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism. PLOS ONE, 11(6), e0157298. https://doi.org/10.1371/journal.pone.0157298
Info
FirstAuthor:: Lin, Hua V.
Author:: Efanov, Alexander M.
Author:: Fang, Xiankang
Author:: Beavers, Lisa S.
Author:: Wang, Xuesong
Author:: Wang, Jingru
Author:: Valcarcel, Isabel C. Gonzalez
Author:: Ma, Tianwei
~
Title:: GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism
Year:: 2016
Citekey:: LinEtAl_2016_GPR142ControlsTryptophanInduced
itemType:: journalArticle
Journal:: PLOS ONE
Volume:: 11
Issue:: 6
Pages:: e0157298
DOI:: 10.1371/journal.pone.0157298
Link
Abstract
GPR142, a putative amino acid receptor, is expressed in pancreatic islets and the gastrointestinal tract, but the ligand affinity and physiological role of this receptor remain obscure. In this study, we show that in addition to L-Tryptophan, GPR142 signaling is also activated by L-Phenylalanine but not by other naturally occurring amino acids. Furthermore, we show that Tryptophan and a synthetic GPR142 agonist increase insulin and incretin hormones and improve glucose disposal in mice in a GPR142-dependent manner. In contrast, Phenylalanine improves in vivo glucose disposal independently of GPR142. Noteworthy, refeeding-induced elevations in insulin and glucose-dependent insulinotropic polypeptide are blunted in Gpr142 null mice. In conclusion, these findings demonstrate GPR142 is a Tryptophan receptor critically required for insulin and incretin hormone regulation and suggest GPR142 agonists may be effective therapies that leverage amino acid sensing pathways for the treatment of type 2 diabetes.